Associate Professor of Medicine, Associate Professor of Pathology, Johns Hopkins University School of Medicine; Medical Director, The Johns Hopkins Hospital Special Coagulation Laboratory, Attending Physician, The Johns Hopkins Hospital Comprehensive Hemo
Hematology
Dr. Michael Streiff, MD
|
|
Give Review
Dr. Michael Streiff is an expert in the field of Hematology. He researched medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Top Doctors:Baltimore Area", "Top Doctors:Washington-Baltimore" and "Top MD". Michael Streiff is a published physician. He published 94 publications, including: 'Risk factors for venous thromboembolism in adults with hemoglobin SC or S(+) thalassemia genotypes.' He accepts all Medicare patients.
Publications
- Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.
- Percutaneous Retrieval of Permanent Inferior Vena Cava Filters.
- Preventability of Hospital-Acquired Venous Thromboembolism.
- Unfractionated heparin dosing for therapeutic antiCoagulation in critically ill obese adults.
- Use of provider-level dashboards and pay-for-performance in venous thromboembolism prophylaxis.
- Patient preferences regarding pharmacologic venous thromboembolism prophylaxis.
- Prevention and treatment of thrombosis associated with central venous catheters in Cancer patients.
- The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
- Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.
- Risk factors for hospital-sssociated venous thromboembolism in the neonatal intensive care unit.
- The Impact of Cancer on the Clinical Outcome of Patients After Inferior Vena Cava Filter Placement: A Retrospective Cohort Study.
- Infection and venous thromboembolism in patients undergoing coloRectal surgery: what is the relationship?
- Hidden Barriers to DeLivery of Pharmacological Venous Thromboembolism Prophylaxis: The Role of Nursing Beliefs and Practices.
- No Association Between Hospital-Reported Perioperative Venous Thromboembolism Prophylaxis and Outcome Rates in Publicly Reported Data.
- An update on type 2B von Willebrand Disease.
- Eculizumab Prevents Recurrent Antiphospholipid Antibody Syndrome and Enables Successful Renal Transplantation.
- Nonadministration of thromboprophylaxis in hospitalized patients with HIV: A missed opportunity for prevention?
- Hospital-Associated Venous Thromboembolism in Children: Incidence and Clinical Characteristics.
- The use of novel Oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery.
- An update on venous thromboembolism in Cancer.
- Venous thromboembolism prophylaxis in hematopoietic stem cell transplantation patients: an international web-based survey of healthcare providers.
- Vena cava filters for management of venous thromboembolism: a clinical review.
- Estimating parsimonious models of longitudinal causal effects using regressions on propensity scores.
- Patterns of non-administration of ordered doses of venous thromboembolism prophylaxis: implications for novel intervention strategies.
- Hidden barriers to deLivery of pharmacologic venous thromboembolism prophylaxis: The role of nursing beliefs and practices.
- Venous thromboembolism in adults with sickle cell Disease: a serious and under-recognized complication.
- Linking processes and outcomes: a key strategy to prevent and report harm from venous thromboembolism in surgical patients.
- Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance.
- Impact of a venous thromboembolism (VTE) prophylaxis "smart order set": Improved compliance, fewer events.
- Is Venous Thromboembolism in ColoRectal Surgery Patients Preventable or Inevitable? One Institution's Experience.
- Sickle cell disease and venous thromboembolism: what the antiCoagulation expert needs to know.
- International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with Cancer.
- Females with subclavian Vein thrombosis may have an increased risk of hypercoagulability.
- Thromboprophylaxis in nonsurgical patients.
- Nature's "silver bullet" for antiCoagulation: mechanism of Zymogen Protein C to Activated Protein C.
- Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist ...
- The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patt...
- Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
- Peripheral blood count abnormalities among patients with hepatitis C in the United States.
- Inhibition of PDE4 phosphodiesterase activity induces growth suppression, apoptosis, glucocorticoid sensitivity, p53, and p21(WAF1/CIP1) proteins in human Acute lympho...
- Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
- Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costs.
- Results of an academic promotion and career path survey of faculty at the Johns Hopkins University School of Medicine.
- ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas.
- Usefulness of clinical prediction rules for the diagnosis of venous thromboembolism: a Systematic review.
- Accuracy of CT in the diagnosis of pulmonary embolism: a Systematic literature review.
- Resection and reconstruction of a massive femOral hemophilic pseudotumor.
- The role of vena caval filters in the management of venous thromboembolism.
- Vena caval filters: a review for intensive care specialists.
- Transhepatic catheter-directed thrombectomy and thrombolysis of Acute superior mesenteric venous thrombosis.
- Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference.
- Catheter-directed thrombolysis with percutaneous rheolytic thrombectomy versus thrombolysis alone in upper and lower extremity Deep vein thrombosis.
- Venous thromboembolic Disease. Clinical practice guidelines in oncology.
- Long-term therapy of venous thromboembolism in Cancer patients.
- Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxis.
- Management of venous thromboembolism: a Systematic review for a practice guideline.
- The NCCN guidelines on venous thromboembolism.
- Catheter-directed thrombolysis of inferior vena cava Thrombosis in a 13-day-old neonate and review of literature.
- Venous thromboembolism in patients with HIV/AIDS: a case-control study.
- Safety of catheter-directed thrombolysis for deep venous thrombosis in Cancer patients.
- A comparison of clinical outcomes with retrievable and permanent inferior vena cava filters.
- Impact of an inpatient antiCoagulation management service on clinical outcomes.
- The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications fo...
- Hematological manifestations of nephropathic cystinosis.
- Venous thromboembolic Disease. NCCN. Clinical practice guidelines in oncology.
- Management of venous thromboembolism in patients with primary and metastatic brain tumors.
- Iatrogenic symptomatic chest wall hematoma after shoulder arthroplasty. A report of two cases.
- Duration of vitamin K antagonist therapy for venous thromboembolism: a Systematic review of the literature.
- Adjunctive percutaneous mechanical thrombectomy for lower-extremity Deep vein thrombosis: clinical and economic outcomes.
- Venous thromboembolism prophylaxis and treatment in Cancer: a consensus statement of major guidelines panels and call to action.
- Diagnosis and initial treatment of venous thromboembolism in patients with Cancer.
- Retrievable vena cava filters: a clinical review.
- Thrombotic Thrombocytopenic purpura at the Johns Hopkins Hospital from 1992 to 2008: clinical outcomes and risk factors for relapse.
- Case report: perioperative use of protein c concentrate for protein C deficiency in THA.
- Acute cardiomyopathy in a patient with thrombotic thrombocytopenic purpura.
- Safer surgery using zymogen protein C concentrate.
- Penny-wise, pound-foolish? Highmark Medicare Services' proposal for antiCoagulation clinic reimbursement.
- The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in Cancer patients.
- Assessment of agreement between INR measures must correspond to a clinical reality.
- Acute renal failure in a patient with antiphospholipid syndrome and immune thrombocytopenic purpura treated with eltrombopag.
- A superior method to report clinically relevant quality information about the point-of-care INR device performance compared with the International Organization for Sta...
- Applying evidence in practice: a qualitative case study of the factors affecting residents'' decisions.
- ABO blood group as a potential risk factor for venous thromboembolism in Acutely injured patients.
- Venous thromboembolism in hospitalized patients with cirrhosis.
- Duplex ultrasound screening for Deep vein thrombosis in asymptomatic trauma patients: a survey of individual trauma surgeon opinions and current trauma center practices.
- Anticoagulation in the management of venous thromboembolism in the Cancer patient.
- Development and implementation of a pharmacist-managed inpatient antiCoagulation monitoring program.
- Are sequential compression devices commonly associated with in-hospital falls? A myth-busters review using the patient safety net database.
- Venous thromboembolic Disease.
- Inflammatory bowel disease-associated thromboembolism: a Systematic review of outcomes with anticoagulation versus catheter-directed thrombolysis.
- Prothrombin complex concentrates for reversal of vitamin K antagonists: assessing the risks.
- The CMS ruling on venous thromboembolism after total knee or hip arthroplasty: weighing risks and benefits.
- Heparin-induced thrombocytopenia screening and management in pediatric patients.
Schools
Johns Hopkins University School of Medicine
Shands Hospital University Fla College Med
Johns Hopkins University
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Top Doctors:Baltimore Area
- Top Doctors:Washington-Baltimore
- Top MD
Education
-
Johns Hopkins University -
University of Florida -
Johns Hopkins University School of Medicine
Hospital
-
Johns Hopkins Hospital -
Johns Hopkins Bayview Medical Center
Drug Facts
| NPI NUMBER | 1932134814 | |
| NPPES Provider LastName | STREIFF | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1419.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 96.0 | |
| Percent Opioid Claims | 6.77 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932134814 |
| Last Name Of The Provider | STREIFF |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Aaron P. Rapoport, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madhu Chaudhry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria Baer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel A. Laheru, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harvinder Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Trishna Goswami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Saul Yanovich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alison R. Moliterno, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chana Weinstock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jocelyn L. Wozney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rosalyn A. Juergens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jamie E. Siegel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. McDevitt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nitya P. Raj, MD |
|
|
Hibba-Tul Rehman, MB BS |